首页> 外国专利> Anti allergic disodiumcromoglycate administration - using dosage scheme which gives sensitisation dose followed by lesser supporting dose

Anti allergic disodiumcromoglycate administration - using dosage scheme which gives sensitisation dose followed by lesser supporting dose

机译:抗过敏性高血糖酸二钠盐-使用剂量方案,给予致敏剂量,然后给予较少的辅助剂量

摘要

Compositions and processes for the administration of disodium 1,3-bis(2-carboxychromon-5-yloxy)-2-hydroxypropane (also known as disodiumcromoglycate or DSCG) and biologues of DSCG to animals for the prophylactic treatment of allergies opt. of a reagin-carrying nature comprise (a) administering a sensitisation dose of DSCG or DSCG biologue which has an inhibitory effect on the allergic manifestation followed by (b) administering a supporting dose of DSCG or DSCG biologue to give a stronger inhibition of the allergic manifestation by the supporting dose than by the sensitisation dose. Dosage scheme to give inhibition of allergic states similar or superior to that previously found but using lower doses than used previously, thus avoiding side-effects and saving on cost of medicament used; e.g. used to treat asthma, allergic rhinitis and food allergies.
机译:选择向动物施用1,3-双(2-羧基色氨酸-5-基氧基)-2-羟基丙烷二钠(也称为高血糖酸二钠或DSCG)的组成和方法以及DSCG的生物类似物,用于预防过敏。携带素的性质包括(a)给予对过敏表现具有抑制作用的敏化剂量的DSCG或DSCG生物制剂,然后(b)给予支持剂量的DSCG或DSCG生物制剂以更强地抑制过敏性通过支持剂量而不是敏化剂量来表现。剂量方案可抑制过敏状态,其作用类似于或优于先前发现的方法,但使用的剂量低于先前使用的剂量,从而避免了副作用并节省了所用药物的成本;例如用于治疗哮喘,过敏性鼻炎和食物过敏。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号